GW & Wade’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-8,583
| Closed | -$427K | – | 387 |
|
2021
Q2 | $427K | Sell |
8,583
-467
| -5% | -$23.2K | 0.02% | 266 |
|
2021
Q1 | $404K | Sell |
9,050
-7,840
| -46% | -$350K | 0.02% | 249 |
|
2020
Q4 | $777K | Buy |
16,890
+1,521
| +10% | +$70K | 0.05% | 159 |
|
2020
Q3 | $723K | Sell |
15,369
-237
| -2% | -$11.1K | 0.06% | 131 |
|
2020
Q2 | $796K | Buy |
15,606
+432
| +3% | +$22K | 0.07% | 128 |
|
2020
Q1 | $719K | Sell |
15,174
-1,660
| -10% | -$78.7K | 0.07% | 122 |
|
2019
Q4 | $989K | Buy |
16,834
+1,320
| +9% | +$77.6K | 0.08% | 122 |
|
2019
Q3 | $828K | Buy |
15,514
+192
| +1% | +$10.2K | 0.07% | 122 |
|
2019
Q2 | $767K | Buy |
+15,322
| New | +$767K | 0.07% | 124 |
|
2019
Q1 | – | Sell |
-10,554
| Closed | -$504K | – | 234 |
|
2018
Q4 | $504K | Sell |
10,554
-5,736
| -35% | -$274K | 0.05% | 139 |
|
2018
Q3 | $818K | Hold |
16,290
| – | – | 0.09% | 121 |
|
2018
Q2 | $821K | Hold |
16,290
| – | – | 0.09% | 118 |
|
2018
Q1 | $796K | Hold |
16,290
| – | – | 0.09% | 119 |
|
2017
Q4 | $722K | Sell |
16,290
-80
| -0.5% | -$3.55K | 0.08% | 120 |
|
2017
Q3 | $831K | Buy |
16,370
+152
| +0.9% | +$7.72K | 0.1% | 107 |
|
2017
Q2 | $874K | Sell |
16,218
-40
| -0.2% | -$2.16K | 0.11% | 104 |
|
2017
Q1 | $857K | Hold |
16,258
| – | – | 0.11% | 101 |
|
2016
Q4 | $783K | Sell |
16,258
-214
| -1% | -$10.3K | 0.13% | 98 |
|
2016
Q3 | $888K | Buy |
+16,472
| New | +$888K | 0.16% | 93 |
|